BioD, LLC is a biotechnology company founded in 2005 that focuses on the development and commercialization of innovative biologic products derived from placental tissues. Their slogan "Enhancing health and healing through the regenerative power of placental tissues" reflects their core mission to explore the regenerative capabilities of the human body.
The company's research primarily revolves around the regenerative potential of amnion and other placental tissues due to their unique biological structure, rich source of undifferentiated stem cells, and unique immune privilege. By recovering tissue from healthy, live donors during childbirth, BioD seeks to create new products that improve patient outcomes and contribute to Advancing Regenerative Medicine.
BioD is committed to developing novel processing techniques that minimally manipulate tissue to leverage the unique biological properties of placental tissues, ultimately improving clinical outcomes and Enhancing Life Through Birth. The company's priority lies in ensuring the Unsurpassed Safety and Quality of their products, from aseptic recovery of tissue at childbirth to timely processing of their allografts.
With a robust product development pipeline, including over 25 patent applications related to their novel products, proprietary processing techniques, and clinical applications, BioD is positioning itself to lead the market segment in the biotechnology and healthcare industries.
There is no investment information
No recent news or press coverage available for BioD.